Hepatitis/MASH

Vosevi is a fixed-dose combination for the treatment of hepatitis C virus.

Vosevi is a fixed-dose combination product containing sofosbuvir, velpatasvir, and voxilaprevir for the re-treatment of adults with chronic hepatitis C.

The first cases were identified in October 2021 at a children’s hospital in Alabama that admitted 5 children with significant liver injury, including some with acute liver failure.

An earlier clinical trial found a higher number of acute myocardial infarction events in those administered HepB-CpG vaccine versus those administered the HepB-alum vaccine.

Getting an appointment with an infectious diseases specialist, particularly after giving birth and while managing a chronic disorder, such as substance use, is difficult, investigators say.

New CDC guidelines based on four decades of safety, immunogenicity, and efficacy data on the HBV vaccine, but with suboptimal coverage in the United States.

Making the process to order a screening for hepatitis C virus easier improved screenings from 42% to approximately 80%.

Study highlights the impressive efficacy of direct-acting antivirals, which have cure rates in the range of 98% in patients with hepatitis C.

Ten quiz questions to assess your knowledge on common symptoms and treatments for hepatitis B.

Glecaprevir and pibrentasvir (Mavyret) is indicated for the treatment of chronic hepatitis C virus genotype 1-6 infections without cirrhosis or with compensated cirrhosis.

Any patients aged 60 years or older who does not meet risk-based recommendations can still receive hepatitis B vaccination.

Ten quiz questions to assess your knowledge on common symptoms and treatments for hepatitis.

A product containing phosphoric acid as well as alcohol successfully neutralized all of the virus particles.

During that time period, patients with high-deductible health plans spent on average $133 per 30-day supply, a cost threshold associated with a more than 50% rate of prescription abandonment, according to the researchers.

Patients with Gilbert's syndrome are born with the condition because of an inherited gene mutation.

Approximately half of people with HCV don't know they're infected, mainly because they have no symptoms.

Chronic HBV increases the risk of developing liver failure, liver cancer, and cirrhosis.

Hepatitis A is most likely to be contracted from contaminated food, water, or close contact with a person or object that's infected.

Risk factors for liver cancer include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, diabetes, and non-alcoholic fatty liver disease.

Harvoni is a fixed-dose combination indicated for the treatment of chronic hepatitis C virus in adults and pediatric patients 3 years of age and older.

Mavyret is indicated for the treatment of patients with chronic hepatitis C virus without cirrhosis or with compensated cirrhosis.

Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.

A huge cost savings could be generated with the success of a hepatitis C vaccine.

According to the US Department of Health and Human Services Office of Minority Health, Asian Americans are 40% more likely to be diagnosed with diabetes and 60% more likely to be diagnosed with renal disease compared to non-Hispanic whites.